The COVID-19 pandemic has seen a wide gap in vaccination rates between wealthy and less well-off countries, sparking demands from several countries for intellectual property rights on vaccines to be lifted.
The Geneva-based group instead proposed a framework to governments and international organizations aimed at improving "the real-time delivery of vaccines, treatments and diagnostics for priority populations in lower-income countries, as determined by health authorities, for future pandemics," it said in a statement on Tuesday.
IFPMA, whose members include COVID-19 vaccine makers such as Pfizer, Moderna and AstraZeneca, called the proposal the Berlin declaration.The group also called for a network of clinical sites to be set up across the world to support the rapid deployment of new treatments and vaccines. "The industry's commitment to reserve part of production of vaccines and treatments at real time for vulnerable populations in low-income countries provides an opportunity to work together strategically to forge a new social contract," he said in the statement.
Walang fair sa mundo